This data suggests that the liver leptin-AMPK-ACC signaling pathway is related to hepatic glucose and lipid metabolic disorder and might explain the etiology of fatty liver incidence in patients with diabetes. This evidence concerns the gene PRKAA2 and Disorder of lipid metabolism.